SCHEMBL7946164

SCHEMBL7946164

Oc1ccc(-c2sc3cc(O)ccc3c2Cl)cc1

nearest known ligand 0.59

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 17/20 0.52
▸ ESR2 Q92731 4/20 0.49
▸ HDAC3 O15379 2/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ HDAC2 Q92769 2/20 0.41
▸ HDAC8 Q9BY41 2/20 0.41
▸ NCOR2 Q9Y618 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7945788 0.86 ESR1 (0.53) ESR1ESR2
SCHEMBL7936791 0.83 PRNP (0.55) ESR1ESR2
SCHEMBL8637183 0.79 ESR1 (0.60) ESR1ESR2
SCHEMBL7945789 0.79 ESR1 (0.52) ESR1ESR2HDAC3HDAC1HDAC2
SCHEMBL8626952 0.76 ESR1 (0.80) ESR1ESR2
SCHEMBL29670038 0.75 RPA1 (0.36) ESR1ESR2
SCHEMBL28770285 0.75 RPA1 (0.36) ESR1ESR2
SCHEMBL1665657 0.75 ESR1 (0.86) ESR1ESR2
SCHEMBL8635521 0.75 ESR1 (0.52) ESR1ESR2HDAC3HDAC1HDAC2
SCHEMBL30898315 0.75 ESR1 (0.52) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6258826-B1 HALOGEN SUBSTITUTED BENZOTHIOPHENE COMPOUNDS WITH CARRIERS ELI LILLY AND COMPANY 2001-07-10 — — US claimed
US-6087378-A THE ACTIVE BENZO(B)THIOPHENE COMPOUNDS FOR TREATING OSTEOPOROSIS AND CARDIOVASCULAR DISORDERS, ESPECIALLY HYPERLIPIDEMIA ELI LILLY AND COMPANY (US) 2000-07-11 — — US claimed
US-6258826-B1 HALOGEN SUBSTITUTED BENZOTHIOPHENE COMPOUNDS WITH CARRIERS ELI LILLY AND COMPANY 2001-07-10 — — US disclosed
US-6087378-A THE ACTIVE BENZO(B)THIOPHENE COMPOUNDS FOR TREATING OSTEOPOROSIS AND CARDIOVASCULAR DISORDERS, ESPECIALLY HYPERLIPIDEMIA ELI LILLY AND COMPANY (US) 2000-07-11 — — US disclosed
Send feedback